Platelet Rich Plasma Market
PUBLISHED: 2021 ID: SMRC20632
SHARE
SHARE

Platelet Rich Plasma Market

Platelet Rich Plasma Market Forecasts to 2028 – Global Analysis By Product (L-PRP, L-PRF), Application (Dermatology, Dentistry), Growth Factor Molecule (VEGF, EGF), End User (Clinics, Physician's office) and By Geography

4.3 (83 reviews)
4.3 (83 reviews)
Published: 2021 ID: SMRC20632

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Platelet Rich Plasma market is accounted for $476.10 million in 2020 and is expected to reach $1,358.12 million by 2028 growing at a CAGR 14.0% during the forecast period. The rise in the number of cosmetic surgeries, approval of new devices & the discovery of new application areas and increase in the number of orthopaedic surgeries & sports injuries are the major factors driving the market growth. However, high cost of the treatment is restraining the market growth.
 

Platelet rich plasma (PRP) is derived from blood, extractor to remove red blood cells and is also known as platelet rich gel, platelet enriched plasma, platelet enriched gel and autologous conditioned plasma. It is produced when the human blood is turned down and the platelet rich plasma gets separate that have a concentration of platelets above the normal values. It aid in blood thickening and also to boost the ligaments, healing of muscles. PRP is extremely rich in healing factors and connective tissue growth. It combines modern technology with body’s own ability to rebuild itself. PRP therapy has an extensive application in cosmetic industry.

Based on product type, the leukocyte rich platelet rich plasma (L-PRP) segment is estimated to have a lucrative growth, due to the potential risks associated with leukocyte rich PRP, this market space is witnessing a significant increase in the commercial pool and number of experimental systems and expanding potential applications across orthopedic, general surgery, and sports medicine. By geography, North America is going to have high growth during forecast period due to rising incidence of orthopedic diseases, rise in demand for cosmetic surgeries along with the approvals of various products by the U.S. FDA and growing awareness amongst the patient population in this particular region.

Some of the key players profiled in the Platelet Rich Plasma Market include AdiStem Ltd, Arthrex Inc, DePuy Synthes Companies (Johnson & Johnson), Dr. PRP USA LLCE, EmCyte Corporation, Glofinn Oy, Zimmer Biomet Holdings Inc, ISTO Biologics, Regen Lab, Arthrex Inc, Stryker Exactech Inc, T-Biotechnology, ThermoGenesis Holdings Inc, and Vertical Spine LLC.

 

Report Coverage

Details

Published Year:

2021

Estimated Market Size in 2020:

USD 476.10 million

Estimated Period:

2020

Compound Annual Growth Rate (CAGR) from 2020 to 2028:

14.0%

Predicted 2028 Value:

USD 1,358.12 million

Forecast Years:

2021-2028

Tables, Graphs & Figures

660

Chapters Covered:

Product, Source/Origin, Application, Growth Factor Molecule, End User and Region

Core Drivers and Opportunities:

  • Rise in the number of cosmetic surgeries
  • Increase in the number of orthopedic surgeries & sports injuries
  • Extending applications of PRP treatment

Restraining Factors & Market Threats:

  • High cost of the treatment

 

Products Covered:
• Instruments
• Leukocyte Rich Platelet Rich Plasma (L-PRP)
• Leukocyte-Rich Platelet Rich Fibrin (L-PRF)
• Platelet Rich Plasma (PRP) Gel
• Pure Platelet Rich Plasma (P-PRP)
• Pure Platelet-Rich Fibrin (P-PRF)

Source /Origin Covered:
• Autologous
• Allogeneic
• Homologous

Applications Covered:
• Sports Medicine
• Cosmetic Surgery and Dermatology
• Orthopedic/Spinal Surgery
• Dermatology
• Ophthalmic Surgery
• Neurosurgery
• General Surgery
• Dentistry
• Cardiac Muscle Injury
• Nerve Injury
• Periodontal Surgery
• Aesthetics
• Other Applications

Growth Factor Molecules Covered:
• Platelet-Derived Growth Factor (PDGF)
• Vascular Endothelial Growth Factor (VEGF)
• Epidermal Growth Factor (EGF)
• Fibroblast Growth Factor-2 (FGF-2)
• Insulin-like Growth Factor (IGF)

End Users Covered:
• Hospitals & Clinics 
• Academic & Research Institutes 
• Orthopedic Clinics
• Cosmetic/Dermatology/Trichology Clinics
• Physician's office/Private Practice
• Ophthalmic Clinics


Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
        
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years (2019, 2020, 2021, 2025, and 2028)
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Key Questions Answered In The Report

The Global Platelet Rich Plasma Market is majorly driven by rise in the number of cosmetic surgeries, approval of new devices & the discovery of new application areasand increase in the number of orthopaedic surgeries & sports injuries.

The leukocyte rich platelet rich plasma (L-PRP) segment is growing at a highest CAGR owing to the potential risks associated with leukocyte rich PRP.

Asia Pacific dominated with a significant market share due to the factors such asincrease in medical tourism, technological advancements and rapid adoption of cosmetic surgeries.

North America market is growing at a highest CAGR owing to rising incidence of orthopedic diseases in the region.

Key players in Platelet Rich Plasma Market include AdiStem Ltd, ArthrexInc, DePuySynthes Companies (Johnson & Johnson), Dr. PRP USA LLCE, EmCyte Corporation, GlofinnOy, Immer Biomet Holdings Inc, ISTO Biologics, Regen Lab, ArthrexInc, Stryker ExactechInc, T-Biotechnology, ThermoGenesis Holdings Inc, Vertical Spine LLC and Zimmer Biomet Company.

Table of Contents

1 Executive Summary    
     
2 Preface    

 2.1 Abstract   
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology   
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions  
     
3 Market Trend Analysis    

 3.1 Introduction   
 3.2 Drivers   
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats   
 3.6 Product Analysis   
 3.7 Application Analysis   
 3.8 End User Analysis   
 3.9 Emerging Markets   
 3.10 Impact of COVID 19   
     
4 Porters Five Force Analysis    

 4.1 Bargaining Power Of Suppliers   
 4.2 Bargaining Power Of Buyers   
 4.3 Threat Of Substitutes   
 4.4 Threat Of New Entrants   
 4.5 Competitive Rivalry   
     
5 Global Platelet Rich Plasma Market, By Product     

 5.1 Introduction   
 5.2 Instruments   
 5.3 Leukocyte Rich Platelet Rich Plasma (L-PRP)   
 5.4 Leukocyte-Rich Platelet Rich Fibrin (L-PRF)   
 5.5 Platelet Rich Plasma (PRP) Gel   
 5.6 Pure Platelet Rich Plasma (P-PRP)   
 5.7 Pure Platelet-Rich Fibrin (P-PRF)   
     
6 Global Platelet Rich Plasma Market, By Source /Origin    

 6.1 Introduction   
 6.2 Autologous   
 6.3 Allogeneic   
 6.4 Homologous   
     
7 Global Platelet Rich Plasma Market, By Application

 7.1 Introduction   
 7.2 Sports Medicine   
 7.3 Cosmetic Surgery and Dermatology   
  7.3.1 Skin Care  
  7.3.2 Hair Care  
 7.4 Orthopedic and Spinal Surgery   
  7.4.1 Arthritis  
  7.4.2 Chronic Tendinitis  
  7.4.3 Bone Repair and Regeneration  
 7.5 Dermatology   
  7.5.1 Androgenic Alopecia  
  7.5.2 Plastic Surgery  
  7.5.3 Cardiac Muscle Injury  
  7.5.4 Dental  
  7.5.5 Nerve Injury  
  7.5.6 Ulcer Healing  
   7.5.6.1 Venous Ulcer 
   7.5.6.2 Traumatic Ulcer 
   7.5.6.3 Diabetic Ulcer 
   7.5.6.4 Pyoderma Gangrenosum Ulcer 
   7.5.6.5 Trophic Ulcer 
   7.5.6.6 Vasculitic Ulcer 
 7.6 Ophthalmic Surgery   
 7.7 Neurosurgery   
 7.8 General Surgery   
 7.9 Dentistry   
 7.10 Cardiac Muscle Injury   
 7.11 Nerve Injury   
 7.12 Periodontal Surgery   
 7.13 Aesthetics   
 7.14 Other Applications   
  7.14.1 Otorhinolaryngology-Head and Neck Surgery  
  7.14.2 Oral and Maxillofacial Surgery  
  7.14.3 Periodontal Surgery  
  7.14.4 Urology  
  7.14.5 Cardiothoracic Surgery  
     
8 Global Platelet Rich Plasma Market, By Growth Factor Molecules    

 8.1 Introduction   
 8.2 Platelet-Derived Growth Factor (PDGF)   
 8.3 Vascular Endothelial Growth Factor (VEGF)   
 8.4 Epidermal Growth Factor (EGF)   
 8.5 Fibroblast  Growth Factor-2 (FGF-2)   
 8.6 Insulin-like Growth Factor (IGF)   
     
9 Global Platelet Rich Plasma Market, By End User    

 9.1 Introduction   
 9.2 Hospitals & Clinics    
 9.3 Academic & Research Institutes   
 9.4 Orthopedic Clinics   
 9.5 Cosmetic/Dermatology/Trichology Clinics   
 9.6 Physician's office/Private Practice    
 9.7 Ophthalmic Clinics   
     
11 Global Platelet Rich Plasma Market, By Geography

 11.1 Introduction   
 11.2 North America   
  11.2.1 US  
  11.2.2 Canada  
  11.2.3 Mexico  
 11.3 Europe   
  11.3.1 Germany  
  11.3.2 UK  
  11.3.3 Italy  
  11.3.4 France  
  11.3.5 Spain  
  11.3.6 Rest of Europe  
 11.4 Asia Pacific   
  11.4.1 Japan  
  11.4.2 China  
  11.4.3 India  
  11.4.4 Australia  
  11.4.5 New Zealand  
  11.4.6 South Korea  
  11.4.7 Rest of Asia Pacific  
 11.5 South America   
  11.5.1 Argentina  
  11.5.2 Brazil  
  11.5.3 Chile  
  11.5.4 Rest of South America  
 11.6 Middle East & Africa   
  11.6.1 Saudi Arabia  
  11.6.2 UAE  
  11.6.3 Qatar  
  11.6.4 South Africa  
  11.6.5 Rest of Middle East & Africa  
     
12 Key Developments    

 12.1 Agreements, Partnerships, Collaborations and Joint Ventures   
 12.2 Acquisitions & Mergers   
 12.3 New Product Launch   
 12.4 Expansions   
 12.5 Other Key Strategies   
     
13 Company Profiling    

 13.1 AdiStem Ltd   
 13.2 Arthrex Inc   
 13.3 DePuy Synthes Companies (Johnson & Johnson)   
 13.4 Dr. PRP USA LLC   
 13.5 EmCyte Corporation   
 13.6 Glofinn Oy   
 13.7 Zimmer Biomet Holdings Inc   
 13.8 ISTO Biologics   
 13.9 Regen Lab, Arthrex Inc   
 13.10 Stryker Exactech Inc   
 13.11 T-Biotechnology   
 13.12 ThermoGenesis Holdings Inc   
 13.13 Vertical Spine LLC   


List of Tables     
1 Global Platelet Rich Plasma Market Outlook, By Region (2019-2028) (US $MN)     
2 Global Platelet Rich Plasma Market Outlook, By Product  (2019-2028) (US $MN)     
3 Global Platelet Rich Plasma Market Outlook, By Instruments (2019-2028) (US $MN)     
4 Global Platelet Rich Plasma Market Outlook, By Leukocyte Rich Platelet Rich Plasma (L-PRP) (2019-2028) (US $MN)     
5 Global Platelet Rich Plasma Market Outlook, By Leukocyte-Rich Platelet Rich Fibrin (L-PRF) (2019-2028) (US $MN)     
6 Global Platelet Rich Plasma Market Outlook, By Platelet Rich Plasma (PRP) Gel (2019-2028) (US $MN)     
7 Global Platelet Rich Plasma Market Outlook, By Pure Platelet Rich Plasma (P-PRP) (2019-2028) (US $MN)     
8 Global Platelet Rich Plasma Market Outlook, By Pure Platelet-Rich Fibrin (P-PRF) (2019-2028) (US $MN)     
9 Global Platelet Rich Plasma Market Outlook, By Source /Origin (2019-2028) (US $MN)     
10 Global Platelet Rich Plasma Market Outlook, By Autologous (2019-2028) (US $MN)     
11 Global Platelet Rich Plasma Market Outlook, By Allogeneic (2019-2028) (US $MN)     
12 Global Platelet Rich Plasma Market Outlook, By Homologous (2019-2028) (US $MN)     
13 Global Platelet Rich Plasma Market Outlook, By Application (2019-2028) (US $MN)     
14 Global Platelet Rich Plasma Market Outlook, By Sports Medicine (2019-2028) (US $MN)     
15 Global Platelet Rich Plasma Market Outlook, By Cosmetic Surgery and Dermatology (2019-2028) (US $MN)     
16 Global Platelet Rich Plasma Market Outlook, By Skin Care (2019-2028) (US $MN)     
17 Global Platelet Rich Plasma Market Outlook, By Hair Care (2019-2028) (US $MN)     
18 Global Platelet Rich Plasma Market Outlook, By Orthopedic and Spinal Surgery (2019-2028) (US $MN)     
19 Global Platelet Rich Plasma Market Outlook, By Arthritis (2019-2028) (US $MN)     
20 Global Platelet Rich Plasma Market Outlook, By Chronic Tendinitis (2019-2028) (US $MN)     
21 Global Platelet Rich Plasma Market Outlook, By Bone Repair and Regeneration (2019-2028) (US $MN)     
22 Global Platelet Rich Plasma Market Outlook, By Dermatology (2019-2028) (US $MN)     
23 Global Platelet Rich Plasma Market Outlook, By Androgenic Alopecia (2019-2028) (US $MN)     
24 Global Platelet Rich Plasma Market Outlook, By Plastic Surgery (2019-2028) (US $MN)     
25 Global Platelet Rich Plasma Market Outlook, By Cardiac Muscle Injury (2019-2028) (US $MN)     
26 Global Platelet Rich Plasma Market Outlook, By Dental (2019-2028) (US $MN)     
27 Global Platelet Rich Plasma Market Outlook, By Nerve Injury (2019-2028) (US $MN)     
28 Global Platelet Rich Plasma Market Outlook, By Ulcer Healing (2019-2028) (US $MN)     
29 Global Platelet Rich Plasma Market Outlook, By Ophthalmic Surgery (2019-2028) (US $MN)     
30 Global Platelet Rich Plasma Market Outlook, By Neurosurgery (2019-2028) (US $MN)     
31 Global Platelet Rich Plasma Market Outlook, By General Surgery (2019-2028) (US $MN)     
32 Global Platelet Rich Plasma Market Outlook, By Dentistry (2019-2028) (US $MN)     
33 Global Platelet Rich Plasma Market Outlook, By Cardiac Muscle Injury (2019-2028) (US $MN)     
34 Global Platelet Rich Plasma Market Outlook, By Nerve Injury (2019-2028) (US $MN)     
35 Global Platelet Rich Plasma Market Outlook, By Periodontal Surgery (2019-2028) (US $MN)     
36 Global Platelet Rich Plasma Market Outlook, By Aesthetics (2019-2028) (US $MN)     
37 Global Platelet Rich Plasma Market Outlook, By Other Applications (2019-2028) (US $MN)     
38 Global Platelet Rich Plasma Market Outlook, By Otorhinolaryngology-Head and Neck Surgery (2019-2028) (US $MN)     
39 Global Platelet Rich Plasma Market Outlook, By Oral and Maxillofacial Surgery (2019-2028) (US $MN)     
40 Global Platelet Rich Plasma Market Outlook, By Periodontal Surgery (2019-2028) (US $MN)     
41 Global Platelet Rich Plasma Market Outlook, By Urology (2019-2028) (US $MN)     
42 Global Platelet Rich Plasma Market Outlook, By Cardiothoracic Surgery (2019-2028) (US $MN)     
43 Global Platelet Rich Plasma Market Outlook, By Growth Factor Molecules (2019-2028) (US $MN)     
44 Global Platelet Rich Plasma Market Outlook, By Platelet-Derived Growth Factor (PDGF) (2019-2028) (US $MN)     
45 Global Platelet Rich Plasma Market Outlook, By Vascular Endothelial Growth Factor (VEGF) (2019-2028) (US $MN)     
46 Global Platelet Rich Plasma Market Outlook, By Epidermal Growth Factor (EGF) (2019-2028) (US $MN)     
47 Global Platelet Rich Plasma Market Outlook, By Fibroblast  Growth Factor-2 (FGF-2) (2019-2028) (US $MN)     
48 Global Platelet Rich Plasma Market Outlook, By Insulin-like Growth Factor (IGF) (2019-2028) (US $MN)     
49 Global Platelet Rich Plasma Market Outlook, By End User (2019-2028) (US $MN)     
50 Global Platelet Rich Plasma Market Outlook, By Hospitals & Clinics  (2019-2028) (US $MN)     
51 Global Platelet Rich Plasma Market Outlook, By Academic & Research Institutes (2019-2028) (US $MN)     
52 Global Platelet Rich Plasma Market Outlook, By Orthopedic Clinics (2019-2028) (US $MN)     
53 Global Platelet Rich Plasma Market Outlook, By Cosmetic/Dermatology/Trichology Clinics (2019-2028) (US $MN)     
54 Global Platelet Rich Plasma Market Outlook, By Physician's office/Private Practice  (2019-2028) (US $MN)     
55 Global Platelet Rich Plasma Market Outlook, By Ophthalmic Clinics (2019-2028) (US $MN)     
     
Note- Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.    

   

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials